Still, most of these studies principally describe OPN and Grem1 expression changes in cardiomyocytes that are exposed to dilatative cardiomyopathy, acute ischemia or ischemic heart disease-induced advanced HF [11,23,25,26]. The gene discussed is GREM1; the disease is dilated cardiomyopathy.